Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors.

  1. Gefard-Gontier, E, Markich, R, Zysman, M, Veillon, R, Daste, A, Domblides, C et al.. Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors. Cancer Immunol Immunother. 2022; :. doi: 10.1007/s00262-022-03180-x. PubMed PMID:35305123 .
Search PubMed

People Involved

All right reserved © immunoconcept.cnrs.fr 2022 by Nivo-Web

Scroll to Top